Anti-Mouse CD314/NKG2D (CX5)

CD314/NKG2D Monoclonal Antibody for FC
Cat No. 65100-1-Ig
Clone No.CX5

Host / Isotype

Rat / IgG1, kappa

Reactivity

Mouse

Applications

FC

D6H12S2489E, Klrk1, NKG2 D, Nkg2d, NKG2D (CD314)

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive FC detected inC57 mouse splenic NK cells

Recommended dilution

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

65100-1-Ig targets CD314/NKG2D in FC applications and shows reactivity with Mouse samples.

Tested Reactivity Mouse
Host / Isotype Rat / IgG1, kappa
Class Monoclonal
Type Antibody
Immunogen Purified Mouse NKG2D protein Predict reactive species
Full Name killer cell lectin-like receptor subfamily K, member 1
GenBank Accession NumberBC057147
Gene Symbol CD314
Gene ID (NCBI) 27007
RRIDAB_3084899
Conjugate Unconjugated
Form Liquid
Purification MethodAffinity purification
UNIPROT IDO54709
Storage Buffer PBS with 0.09% sodium azide.
Storage ConditionsStore at 2-8°C. Stable for one year after shipment.

Background Information

CD314, also known as NKG2D or Killer cell lectin-like receptor subfamily K member 1 (KLRK1), is a type II lectin-like transmembrane stimulatory receptor (PMID: 8436421). In mice, CD314 is expressed on NK cells, activated CD8(+) T cells and macrophages, and subsets of TCR gamma delta (+) and NK1.1 (+) T cells (PMID: 12150888). Various subfamilies of MHC class I-related glycoproteins have been identified as the ligands for mouse CD314, including RAET1A, RAET1B, RAET1C, RAET1D, RAET1E, H60 and MULT1 (PMID: 31720075).

Protocols

Product Specific Protocols
FC protocol for CD314/NKG2D antibody 65100-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...